Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

May 10, 2023

Study Completion Date

February 8, 2024

Conditions
Tobacco Use
Interventions
OTHER

Test Product A

Use of Test Product A in controlled use and ad libitum use sessions

OTHER

Test Product B

Use of Test Product B in controlled use and ad libitum use sessions

OTHER

Test Product C

Use of Test Product C in controlled use and ad libitum use sessions

OTHER

Test Product D

Use of Test Product D in controlled use and ad libitum use sessions

OTHER

Test Product E

Use of Test Product E in controlled use and ad libitum use sessions

OTHER

Reference Product F: Subjects' OBMST

Use of Reference Product F in controlled use and ad libitum use sessions. The subjects' Own Brand Moist Smokeless Tobacco (OBMST) reference products used in this study were commercially available and had been reported by the subjects as the brands they usually consume.

Trial Locations (2)

65802

QPS Bio-Kinetic, Springfield

72712

Pillar Clinical Research LLC, Bentonville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Altria Client Services LLC

INDUSTRY